Objective To investigate the effect of irbestartan on serum advanced glycosylation end products-peptide(AGE-P) and monocyte chemoatt ractant protein-1(MCP-1) in patients with nephropathy due to type 2 diabetes(DN).

• 目的:探讨伊贝沙坦对2型糖尿病肾病患者血清糖基化终产物-肽(AGE-肽)和单核细胞趋化蛋白-1(MCP-1)水平的影响。